How do we balance the speed of developing new drugs with the confidence of knowing they really work? In "Bioethics & Drug" Regulation, Greenwall Faculty Scholar, Holly Fernandez Lynch, JD, explains how bioethics can help draw attention to the tradeoffs at the heart of FDA decision-making and inform policy that supports both high-quality research and facilitates access to new drugs for patients who might benefit from them even before they’ve been approved.
The Greenwall Foundation seeks to make bioethics integral to decisions in health care, policy, and research. It awards approximately $3-4 million annually in support of its mission to expand bioethics knowledge to improve clinical, biomedical, and public health decision-making, policy, and practice. To learn more about the Foundation, visit greenwall.org
14 дек 2021
